Strait Access Technologies

Strait Access Technologies (SAT) is a private medical device company based in Cape Town, South Africa. Founded in 2012, SAT focuses on developing, manufacturing, and marketing innovative cardiac-related medical devices, particularly heart valve therapies for Rheumatic Heart Disease (RHD) and Degenerative Heart Disease (DHD). The company emerged from a collaboration between clinicians and medical engineers at Groote Schuur Hospital, aiming to create cost-effective, minimally invasive solutions for patients in developing countries. SAT's product lineup includes durable transcatheter aortic valves, such as the SAT Mitral Clip and SATH Heart Valve, designed for younger patients with RHD. These technologies facilitate minimally invasive procedures, eliminating the need for open-heart surgery and providing essential treatment options in resource-limited settings. The company has received regulatory approval for clinical implants and operates from advanced facilities at the University of Cape Town, employing a multidisciplinary team of around 60 professionals dedicated to improving healthcare outcomes for underserved populations.

• Employees 54
• Founded 2012